These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9216701)

  • 21. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
    Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
    Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A
    Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
    Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells.
    Yu ST; Chen TM; Tseng SY; Chen YH
    Biochem Biophys Res Commun; 2007 Jun; 358(1):79-84. PubMed ID: 17482571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol.
    Li L; Jiang AC; Dong P; Wang H; Xu W; Xu C
    Ann Surg Oncol; 2009 May; 16(5):1421-8. PubMed ID: 19247716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
    Ihnat MA; Lariviere JP; Warren AJ; La Ronde N; Blaxall JR; Pierre KM; Turpie BW; Hamilton JW
    Clin Cancer Res; 1997 Aug; 3(8):1339-46. PubMed ID: 9815817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance].
    Wei L; Song XR; Wang XW; Li M; Z uo WS
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):445-8. PubMed ID: 17152492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Obstruction of the upper urinary tract caused by a malignant retrovesicular schwannoma. Therapeutic strategy].
    González Enguita C; Caro Cebrián C; Gil Sanz MJ; Rodríguez Vela L; Valero Palomero I; Roncalés Badal A; Rioja Sanz C; Rioja Sanz LA
    Actas Urol Esp; 1990; 14(1):46-9. PubMed ID: 2339652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemotherapy of metastatic malignant schwannoma with vincristine, adriamycin, cyclophosphamide, and imidazole carboxamide: a case report.
    Goldman RL; Jones SE; Heusinkveld RS
    Cancer; 1977 May; 39(5):1955-8. PubMed ID: 858125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [DTIC, CTX, ADM and VCT in children with metastatic neuroblastoma].
    Ghibaudo P; Pastore G; Cordero di Montezemolo L; Brach del Prever A; Madon E
    Minerva Pediatr; 1983 Feb; 35(4):139-43. PubMed ID: 6855711
    [No Abstract]   [Full Text] [Related]  

  • 33. Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs.
    Stein U; Walther W; Wunderlich V
    Eur J Cancer; 1994; 30A(10):1541-5. PubMed ID: 7833115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaplastic malignant neoplasms: diagnosis and treatment.
    Bedikian AY; Mackay B; Luna M; Valdivieso M
    South Med J; 1981 Apr; 74(4):392-6. PubMed ID: 7221654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of multidrug resistance gene expression in human osteosarcomas.
    Lee PD; Noble-Topham SE; Bell RS; Andrulis IL
    Br J Cancer; 1996 Oct; 74(7):1046-50. PubMed ID: 8855972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with vincristine sulfate (NSC-67574) and cyclophosphamide (NSC-26271) for generalized malignant schwannoma--a case report.
    Valdes OS; Maurer HM
    Cancer Chemother Rep; 1970 Feb; 54(1):65-8. PubMed ID: 5527013
    [No Abstract]   [Full Text] [Related]  

  • 37. Multidrug-resistance gene (mdr1) expression in human tumor xenografts.
    Abe Y; Nakamura M; Ohnishi Y; Inaba M; Ueyama Y; Tamaoka N
    Int J Oncol; 1994 Dec; 5(6):1285-92. PubMed ID: 21559711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant schwannoma of the clitoris in a 1-year-old child.
    Thomas WJ; Bevan HE; Hooper DG; Downey EJ
    Cancer; 1989 Jun; 63(11):2216-9. PubMed ID: 2720570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Malignant schwannoma].
    Nagel K; Ghussen F
    Med Klin Prax; 1982 Jan; 77(2):31-41. PubMed ID: 6803116
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bone tumors (primary and metastatic)].
    Dosen M; Krajcinović J
    Med Pregl; 1972; 25(3):123-6. PubMed ID: 5034436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.